Here’s Why the First Cure for HIV Could Emerge from Maryland These Five Life Science Organizations are Striving to Cure HIV November 5, 2019 For those that lived through the devastation and horror of the HIV/AIDS epidemic of the early 1980s, effective treatment, let alone a cure for Human Immunodeficiency Virus (HIV), seemed unimaginable. Some [….]
The Story of Maryland’s Cell and Gene Therapy Cluster is Shared Loud and Clear at Inaugural Bio Innovation Conference October 8, 2019 On Monday morning in Bethesda, Maryland hundreds of industry leaders emerged from a large ballroom at the inaugural Bio Innovation Conference, hosted by Maryland Life Sciences, a division of the Maryland Tech Council. [….]
Presented by Maryland Life Sciences (MDLS), a division of the Maryland Tech Council, the Bio Innovation Conference showcases Maryland’s innovation and success in the life sciences industry. The Bio Innovation Conference will connect more than 300 top life sciences professionals in the region with leading global brands, venture capitalists and promising startups, while embracing the [….]
Serial Entrepreneurs of the Biohealth Capital Region A strong group of entrepreneurs ready and willing to innovate, fund and lead new bioscience companies is essential to the creation and sustainability of top-tier biohealth clusters. It is often referenced that the BioHealth Capital Region (BHCR) lacks a deep enough pool of qualified executive talent that is [….]
Reprogramming the Human Computer: Silicon Valley Meets Cell and Gene Therapy How will Cell and Gene Therapy Usher in a New Industrial Revolution? Cell and gene therapy companies are on the verge of transforming how we treat unmet medical needs such as cancer, rare diseases, genetic disorders and diabetes, to name only a few. By [….]
Why Developing Cures for Rare Disease Isn’t So Rare Anymore These Six Maryland Biotech Companies Are Seeing Success in Targeting Rare Diseases September 3, 2019 Groundbreaking technology and scientific advancements, including cell and gene therapy, have fundamentally changed the way life science companies see rare disease drug development. Life science giants like Pfizer, Merck and [….]
Five Cell and Gene Therapy Companies that Are Changing the Landscape of the Field
BIO 2019 Maryland Pavilion
BioBuzz Panel on Drug Development in Rare Diseases with regional leaders from AstraZeneca, REGENXBIO, American Gene Technologies, GeneDx and Jeeva Informatics
MCEDC Interview: Jeff Galvin, CEO & Founder of American Gene Technologies In the latest of the ‘Built for Bio‘ interview series, MCEDC CEO, David Petr, discovers how Jeff is using the availability of raw talent and novel technology unique to Montgomery County, MD to develop potential cures for HIV and cancers using cell and gene [….]
